Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in India Women
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Infertility
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Single (Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 21 years and 40 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04773353
- Collaborators
- Not Provided
- Investigators
- Study Director: Global Clinical Compliance Ferring Pharmaceuticals